NCT03070392 2026-03-17Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal MelanomaImmunocore LtdPhase 2 Completed378 enrolled 15 charts 1 FDA
NCT02362594 2026-03-05MK-3475-054Merck Sharp & Dohme LLCPhase 3 Active not recruiting1,019 enrolled 16 charts 1 FDA